We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1mfp

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1mfp" size="450" color="white" frame="true" align="right" spinBox="true" caption="1mfp, resolution 2.33&Aring;" /> '''E. coli Enoyl Reduct...)
Current revision (07:43, 14 February 2024) (edit) (undo)
 
(15 intermediate revisions not shown.)
Line 1: Line 1:
-
[[Image:1mfp.gif|left|200px]]<br /><applet load="1mfp" size="450" color="white" frame="true" align="right" spinBox="true"
 
-
caption="1mfp, resolution 2.33&Aring;" />
 
-
'''E. coli Enoyl Reductase in complex with NAD and SB611113'''<br />
 
-
==Overview==
+
==E. coli Enoyl Reductase in complex with NAD and SB611113==
-
Bacterial enoyl-ACP reductase (FabI) is responsible for catalyzing the, final step of bacterial fatty acid biosynthesis and is an attractive, target for the development of novel antibacterial agents. Previously we, reported the development of FabI inhibitor 4 with narrow spectrum, antimicrobial activity and in vivo efficacy against Staphylococcus aureus, via intraperitoneal (ip) administration. Through iterative medicinal, chemistry aided by X-ray crystal structure analysis, a new series of, inhibitors has been developed with greatly increased potency against, FabI-containing organisms. Several of these new inhibitors have potent, antibacterial activity against multidrug resistant strains of S. aureus, and compound 30 demonstrates exceptional oral (po) in vivo efficacy in a, S. aureus infection model in rats. While optimizing FabI inhibitory, activity, compounds 29 and 30 were identified as having low micromolar, FabK inhibitory activity, thereby increasing the antimicrobial spectrum of, these compounds to include the FabK-containing pathogens Streptococcus, pneumoniae and Enterococcus faecalis. The results described herein support, the hypothesis that bacterial enoyl-ACP reductases are valid targets for, antibacterial agents.
+
<StructureSection load='1mfp' size='340' side='right'caption='[[1mfp]], [[Resolution|resolution]] 2.33&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[1mfp]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MFP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1MFP FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.33&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=IDN:(E)-N-METHYL-N-(1-METHYL-1H-INDOL-3-YLMETHYL)-3-(7-OXO-5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-3-YL)-ACRYLAMIDE'>IDN</scene>, <scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1mfp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1mfp OCA], [https://pdbe.org/1mfp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1mfp RCSB], [https://www.ebi.ac.uk/pdbsum/1mfp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1mfp ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/FABI_ECOLI FABI_ECOLI] Catalyzes the reduction of a carbon-carbon double bond in an enoyl moiety that is covalently linked to an acyl carrier protein (ACP). Involved in the elongation cycle of fatty acid which are used in the lipid metabolism and in the biotin biosynthesis.<ref>PMID:8119879</ref> <ref>PMID:7592873</ref> <ref>PMID:20693992</ref>
 +
== Evolutionary Conservation ==
 +
[[Image:Consurf_key_small.gif|200px|right]]
 +
Check<jmol>
 +
<jmolCheckbox>
 +
<scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/mf/1mfp_consurf.spt"</scriptWhenChecked>
 +
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
 +
<text>to colour the structure by Evolutionary Conservation</text>
 +
</jmolCheckbox>
 +
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1mfp ConSurf].
 +
<div style="clear:both"></div>
-
==About this Structure==
+
==See Also==
-
1MFP is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with SO4, NAD and IDN as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1MFP OCA].
+
*[[Enoyl-Acyl-Carrier Protein Reductase 3D structures|Enoyl-Acyl-Carrier Protein Reductase 3D structures]]
-
 
+
== References ==
-
==Reference==
+
<references/>
-
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK., Seefeld MA, Miller WH, Newlander KA, Burgess WJ, DeWolf WE Jr, Elkins PA, Head MS, Jakas DR, Janson CA, Keller PM, Manley PJ, Moore TD, Payne DJ, Pearson S, Polizzi BJ, Qiu X, Rittenhouse SF, Uzinskas IN, Wallis NG, Huffman WF, J Med Chem. 2003 Apr 24;46(9):1627-35. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=12699381 12699381]
+
__TOC__
-
[[Category: Enoyl-[acyl-carrier-protein] reductase (NADH)]]
+
</StructureSection>
[[Category: Escherichia coli]]
[[Category: Escherichia coli]]
-
[[Category: Single protein]]
+
[[Category: Large Structures]]
-
[[Category: Burgess, W.J.]]
+
[[Category: Burgess WJ]]
-
[[Category: Elkins, P.A.]]
+
[[Category: DeWolf Jr WE]]
-
[[Category: Head, M.S.]]
+
[[Category: Elkins PA]]
-
[[Category: Huffman, W.F.]]
+
[[Category: Head MS]]
-
[[Category: Jakas, D.R.]]
+
[[Category: Huffman WF]]
-
[[Category: Janson, C.A.]]
+
[[Category: Jakas DR]]
-
[[Category: Jr., W.E.DeWolf.]]
+
[[Category: Janson CA]]
-
[[Category: Keller, P.M.]]
+
[[Category: Keller PM]]
-
[[Category: Manley, P.J.]]
+
[[Category: Manley PJ]]
-
[[Category: Miller, W.H.]]
+
[[Category: Miller WH]]
-
[[Category: Moore, T.D.]]
+
[[Category: Moore TD]]
-
[[Category: Newlander, K.A.]]
+
[[Category: Newlander KA]]
-
[[Category: Payne, D.J.]]
+
[[Category: Payne DJ]]
-
[[Category: Pearson, S.]]
+
[[Category: Pearson S]]
-
[[Category: Polizzi, B.J.]]
+
[[Category: Polizzi BJ]]
-
[[Category: Qiu, X.]]
+
[[Category: Qiu X]]
-
[[Category: Rittenhouse, S.F.]]
+
[[Category: Rittenhouse SF]]
-
[[Category: Seefeld, M.A.]]
+
[[Category: Seefeld MA]]
-
[[Category: Uzinskas, I.N.]]
+
[[Category: Uzinskas IN]]
-
[[Category: Wallis, N.G.]]
+
[[Category: Wallis NG]]
-
[[Category: IDN]]
+
-
[[Category: NAD]]
+
-
[[Category: SO4]]
+
-
[[Category: enoyl reductase]]
+
-
[[Category: enoyl-acp reductase]]
+
-
[[Category: fabi]]
+
-
 
+
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 21:23:14 2007''
+

Current revision

E. coli Enoyl Reductase in complex with NAD and SB611113

PDB ID 1mfp

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools